- Press Releases
- Notices
Press Releases To List
-
- Oct.20.2021R & D
- Opdivo® Intravenous Infusion Approved for the Treatment of Gastric Cancer, Gastroesophageal Junction Cancer and Esophageal Adenocarcinoma in Combination with Chemotherapy in Taiwan
-
- Oct.19.2021Corporate
- Notice on Decision of Recipients of the "Osamu Hayaishi Memorial Scholarship for Study Abroad" of the FY2022 Japanese Biochemical Society
-
- Oct.04.2021R & D
- European Medicines Agency Validates Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as First-Line Treatment for Patients with Unresectable or Metastatic Melanoma
Notices To List
About
We Want to Deliver New Drugs
to the World with a Wish.
For more than 300 years since its foundation in 1717, working for people’s health.
Diseases still unconquered. Patients' wishes still unfulfilled.
ONO, with a wish to meet these medical needs, devotes all its efforts to drug discovery.
